Testing For Influenza and COVID-19
Emerging from one of the greatest public health crises of all time, rapid antigen tests have revolutionized our approach to infection control.
Now, let’s focus on influenza, a virus similar in danger to Covid-19 yet more familiar to us. Despite some underestimating its severity, influenza has been the focal point of numerous epidemics and pandemics, with the 1918 outbreak marking the first of three major events. The most recent pandemic was the 2009 swine flu outbreak.
Influenza A and B viruses cause the flu, a highly contagious respiratory illness characterized by symptoms such as fever, chills, headache, fatigue, muscle aches, and coughing. In Australia, flu season typically spans from May to October. Vaccination is the primary preventive measure, although breakthrough infections can occur. Early detection through Influenza A and B testing allows for timely administration of antiviral medication, crucial for containment.
Acknowledging the disruptive impact of influenza on workplaces, especially during winter, corporate entities are actively seeking strategies to retain staff and ensure a safe return to work environments. The contagious nature of the virus emphasizes the importance of proactive measures.
Drawing lessons from the Covid-19 pandemic, early symptom recognition and self-isolation have significantly mitigated its impact on productivity. A similar approach can be applied to influenza, given its comparable consequences.
BST Health currently supplies various types of rapid antigen tests, some which will only detect COVID-19 strains, others that can detect other strains like Influenza A, Influenza B, and RSV.
Healthcare professionals play a pivotal role in championing the adoption of rapid antigen testing strategies within their centres. By advocating for evidence-based practices and facilitating staff training, clinicians can elevate the standard of care and safeguard patients against infectious threats.
The availability of rapid antigen tests for combined Covid-19 and influenza detection heralds a pivotal development in disease control. By harnessing the full potential of these diagnostic tools, clinicians can uphold the highest standards of patient care and safeguard public health in an ever-evolving landscape of infectious diseases.
